Recent #CBD / #Cannabis
Acquisitions (OTC: $SIML) (TSX:
$WEED.TO) (NYSE: $CGC) (CSE: $CRFT.C) (CSE: $IAN.C) (OTCQX: $ITHUF)
Point Roberts WA,
Delta BC – July 1, 2019 - Investorideas.com, a leading investor news resource covering
hemp and cannabis stocks releases a multi-media snapshot reporting on recent
acquisitions in the CBD cannabis space.
Viridian’s
Deal Tracker recently noted, “Acquisitions of companies in the hemp sector
accelerate worldwide as industrial and consumer hemp/CBD markets develop.”
Driving
the acquisition flurry; the collective market for CBD sales is expected to
exceed $20 billion in the United States by 2024, according to BDS Analytics and
Arcview Market Research.
Aiming to capitalize on this, Simlatus Corporation
(OTC PINK:SIML), a holding
company focused on opportunities in the cannabis space just announced that the
Company is cleaning up corporately to be better positioned for acquisitions in
the future.
Read this in full at https://www.investorideas.com/news/2019/cannabis/07011Stocks-Acquisitions.asp
From the news - “During the
past several months the Company has retired and returned to treasury $2.7M in
Convertible Debt using its cash reserves to quarantine toxic conversions, stock
dilution and preserve its equity.“
Continued: Richard Hylen, Chairman
and CEO stated “Our shareholders and management team have been on an impressive
run ever since the company expanded its footprint into the cannabis sector with
our most recent acquisition of Proscere Bioscience. With this acquisition, the
company gained access to a cold-water CBD extraction Technology that presents
an exciting opportunity on revenue generation. With the acquisition, the
company has gained access to a valuable asset capable of strengthening its
revenue base, with a current $2.8M in its first purchase order, and commitments
of $275M over the next 5 years. The company has already set sights on Canada,
USA, and Europe as it embarks on an aggressive commercialization drive for the
cold-water CBD extraction systems.”
Cannabis leader, Canopy Growth Corporation (TSX:WEED) (NYSE:CGC) is also
completing an acquisition in extraction technology, announcing on June 26th that it has completed a transaction to acquire Saskatoon-based
bio-product extractor KeyLeaf Life Sciences, related entities and intellectual
property. “Canopy Growth has been
working closely with KeyLeaf – formerly known as POS Bio-Sciences – as a
trusted partner building out extraction processes and technology for the past
year as it refines its scale extraction model for Canadian and global markets.
As previously disclosed, Canopy Growth assumed control of KeyLeaf for
accounting purposes in November 2018. As such, KeyLeaf’s financial results were
consolidated in the Company’s fiscal 2019 financial statements. Through the
transaction, the Company is acquiring a large-scale Canadian extraction
facility as well as an extraction-related facility in the United States to
support the Company’s US CBD expansion.”
Continued: “With over 45 years of
experience in the canola, nutraceutical, cosmetic and bio-product industries,
KeyLeaf is a recognized leading authority with significant intellectual
property relating to plant-based extraction and ingredients. The extensive
experience of KeyLeaf’s chemists, engineers, and operators will remain within
the organization to further refine the cannabinoid extraction process and will
support Canopy Growth in the design, training, oversight, and implementation of
additional extraction sites around the world.”
Continued: “KeyLeaf has been working
closely with Canopy Growth over the past year to retrofit its Saskatchewan
facility to advance technology development and commercialization, in order to
process hemp and cannabis biomass, and to conduct pre- and post-extraction
processes. It is anticipated the
facility, which is currently in the Health Canada licensing process, will be
able to process up to 5,000 kg of input materials daily when operational.”
Continued: “Canopy Growth intends to
leverage this facility, along with other owned and partner extraction options,
to process its over 5,000 acres of Canadian CBD hemp production, over 160 acres
of outdoor cannabis production, as well as any extraction materials outputted
from its over 4 million square feet of greenhouse growing operations. Then it’s off to Smiths Falls to produce the
best possible, IP-protected products out there!”
Looking at other recent acquisition news in the sector,
Pasha Brands Ltd. (CSE: CRFT) (OTC:CRFTF), Canada's
largest craft cannabis brands organization, announced on June 24th the acquisition of the CBD Therapeutics brand – a leading
pre-legalization manufacturer and purveyor of cannabidiol (CBD) product based
in British Columbia.
Continued: “Since its
inception, CBD Therapeutics has supplied solvent-less full spectrum and
isolated CBD formulations to the pre-legalization market throughout Canada, and
increased access to both products and education. Since ceasing sales on October
17, 2018, CBD Therapeutics has been preparing to enter the regulated framework.
Pasha has acquired all of the brand's trademarks, names and intellectual
property and will re-launch the brand in the Canadian regulated market in the
very near future.”
Continued: "Joining
Pasha Brands is yet another step forward in our mission of making CBD products
more accessible," said James Whitehead, CEO of CBD Therapeutics.
"Working with a collective of smart, like minded individuals and brands
will help open opportunities for CBD Therapeutics and aid our growth. It
already has."
Finalizing a previously announced acquisition,
iAnthus Capital Holdings, Inc. (CSE: IAN, OTCQX: ITHUF), which owns,
operates and partners with best-in-class regulated cannabis operations across
the United States, announced on June 28th that its US subsidiary has closed the previously
announced acquisition of CBD For Life, a top-ranked, national CBD brand in the
US.
Continued: “CBD For Life has
experienced accelerating revenue growth, from both existing customers and new
account additions—representing approximately 50% quarter over quarter growth.
CBD For Life's products are sold directly to consumers online at
www.cbdforlife.us as well as in over 1,000 retail locations in 46 states, with
a dedicated sales channel working with national retailers to on-board new
locations weekly. CBD For Life's roster of national retailers include Urban
Outfitters, Paper Source, Of a Kind, Olympia Sports, and Weis Markets, with
others soon to be announced. Since announcing the Urban Outfitters relationship
in mid-April 2019, the retailer has expanded the lineup of CBD For Life
products it carries and the number of retail locations in which it offers them.
CBD For Life's CBD-infused wellness, self-care, and beauty products have been
featured in a wide range of cable, online, and print publications—including on
NBC's Today Show and Telemundo47.”
Continued: “According
to industry experts, U.S. retail sales of CBD consumer products are estimated
to have been between $600 million and $2 billion in 2018. As a growing number
of CBD brands and product types become increasingly available through diverse
retail channels, the CBD market is projected to generate $16 billion in U.S.
retail sales by 2025. Research has shown that nearly 7% of the U.S. population
in January of 2019 reported using CBD as a supplement, and that number is
expected to grow to at least 10% by 2025.”
“CBD sales have
exploded in the past several months, but there’s still a long way to go when it
comes to consumer, retailer, and manufacturer knowledge,” said Jessica Lukas,
Vice President of Consumers Insights at BDS Analytics. “56 percent of adults
21+ do not know or are confused about the differences between THC and CBD.”
As the consumer
matures, so will the industry and the hunt for acquisitions will continue to
find the best in breed within the sector.
Read the full article/snapshot on
Investorideas.com
For investors
following cannabis stocks, Investor Ideas has created a stock directory of publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX
Marijuana/Hemp Stocks
About Investorideas.com - News that Inspires
Big Investing Ideas
Investorideas.com is a recognized news source
publishing third party news and press releases plus we create original
financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts and videos talking about
cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water,
renewable energy and more . Investorideas.com original branded content includes
the daily Crypto
Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis
News and Stocks on the Move podcast and column,
Cleantech and Climate Change Podcast and
the AI Eye Podcast and column covering developments in AI.
Follow us on Cannabis Social Media
Disclaimer/Disclosure: Investorideas.com is a digital publisher of
third party sourced news, articles and equity research as well as creates
original content, including video, interviews and articles. Original content
created by investorideas is protected by copyright laws other than syndication
rights. Our site does not make recommendations for purchases or sale of stocks,
services or products. Nothing on our sites should be construed as an offer or
solicitation to buy or sell products or securities. All investing involves risk
and possible losses. This site is currently compensated for news publication
and distribution, social media and marketing, content creation and more.
Disclosure is posted for each compensated news release, content published
/created if required but otherwise the news was not compensated for and was
published for the sole interest of our readers and followers. Contact
management and IR of each company directly regarding specific questions.
Disclosure: this news
article SIML is a paid for service( two thousand ) on Investorideas.com - third party . More
disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global
investors must adhere to regulations of each country. Please read
Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Contact Investorideas.com
800-665-0411
Get more Marijuana,
hemp & cannabis stock investor ideas-
news, articles, podcasts and stock directories
No comments:
Post a Comment